Atlas Trials

Trial to Evaluate the Safety and Immunogenicity of Multivalent Pneumococcal Vaccines in Japanese Adults 18 to 49 Years of Age

Clinical trial NCT03642847 · COMPLETED

Trial details

NCT number
NCT03642847
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Pneumococcal Infections
Start date
2018-08-29
Primary completion
2019-03-29
Enrollment
104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.